Carlos Esteban

Biography

Carlos has a PhD in Biochemistry from the University of Valencia (Spain) and an MBA from Imperial College Business School (UK). He was a postdoctoral researcher at University of Texas Southwestern Medical Center (USA) and at Imperial College London. From 2012, Carlos works in the Life Sciences team of Caixa Capital Risc, the venture capital arm of ”la Caixa”, an investor that provides equity and convertible loans to innovative companies in their early stages. Caixa Capital Risc manages a capital of 154 million euro and invests mainly in Spanish companies in the following fields: Healthcare/ Life sciences (therapeutic treatments, drug development, medical devices, and healthcare services), TIME (corporate software, communications equipment, and Internet/mobile business) and Industrial technology (new materials, sustainability, process technology, etc). Carlos is also board member at Sagetis Biotech, Biótica Bioquímica Analítica, iMicroQ and Omnia Molecular.

Research Interest

Biochemistry, Clinical studies